Cargando…
Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
BACKGROUND: Despite the increased utilisation of Managed Entry Agreements (MEAs), empirical studies assessing their impact on achieving better access to medicines remains scarce. In this study we evaluated the role of MEAs on enhancing availability of and timely access to a sample of oncology medici...
Autores principales: | Efthymiadou, Olina, Kanavos, Panos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392357/ https://www.ncbi.nlm.nih.gov/pubmed/35987627 http://dx.doi.org/10.1186/s12913-022-08437-w |
Ejemplares similares
-
Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries
por: Efthymiadou, Olina
Publicado: (2022) -
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
por: Ferrario, Alessandra, et al.
Publicado: (2017) -
Does external reference pricing deliver what it promises? Evidence on its impact at national level
por: Kanavos, Panos, et al.
Publicado: (2019) -
Managed entry agreements
por: Muscolo, Luisa AA, et al.
Publicado: (2014) -
A Proposal for Value-Based Managed Entry Agreements in an Environment of Technological Change and Economic Challenge for Publicly Funded Healthcare Systems
por: Xoxi, Entela, et al.
Publicado: (2022)